Sardomozide dihydrochloride is primarily utilized in the field of pharmacology for its potential therapeutic effects. It is being investigated for its role in treating neurological disorders, particularly those involving cognitive impairments. Research suggests that it may help in enhancing memory and learning capabilities by modulating specific neurotransmitter systems in the brain. Additionally, it is being studied for its potential use in managing mood disorders, such as depression and anxiety, due to its influence on brain chemistry. The compound is also explored for its neuroprotective properties, which could be beneficial in conditions like Alzheimer's disease or other neurodegenerative disorders. Ongoing studies aim to further understand its efficacy and safety profile for clinical applications.